Alert button
Picture for Maksim Sipos

Maksim Sipos

Alert button

Causal Analysis of the TOPCAT Trial: Spironolactone for Preserved Cardiac Function Heart Failure

Add code
Bookmark button
Alert button
Nov 23, 2022
Francesca E. D. Raimondi, Tadhg O'Keeffe, Hana Chockler, Andrew R. Lawrence, Tamara Stemberga, Andre Franca, Maksim Sipos, Javed Butler, Shlomo Ben-Haim

Figure 1 for Causal Analysis of the TOPCAT Trial: Spironolactone for Preserved Cardiac Function Heart Failure
Figure 2 for Causal Analysis of the TOPCAT Trial: Spironolactone for Preserved Cardiac Function Heart Failure
Figure 3 for Causal Analysis of the TOPCAT Trial: Spironolactone for Preserved Cardiac Function Heart Failure
Figure 4 for Causal Analysis of the TOPCAT Trial: Spironolactone for Preserved Cardiac Function Heart Failure
Viaarxiv icon

Data Generating Process to Evaluate Causal Discovery Techniques for Time Series Data

Add code
Bookmark button
Alert button
Apr 16, 2021
Andrew R. Lawrence, Marcus Kaiser, Rui Sampaio, Maksim Sipos

Figure 1 for Data Generating Process to Evaluate Causal Discovery Techniques for Time Series Data
Figure 2 for Data Generating Process to Evaluate Causal Discovery Techniques for Time Series Data
Figure 3 for Data Generating Process to Evaluate Causal Discovery Techniques for Time Series Data
Figure 4 for Data Generating Process to Evaluate Causal Discovery Techniques for Time Series Data
Viaarxiv icon

Unsuitability of NOTEARS for Causal Graph Discovery

Add code
Bookmark button
Alert button
Apr 12, 2021
Marcus Kaiser, Maksim Sipos

Figure 1 for Unsuitability of NOTEARS for Causal Graph Discovery
Figure 2 for Unsuitability of NOTEARS for Causal Graph Discovery
Figure 3 for Unsuitability of NOTEARS for Causal Graph Discovery
Figure 4 for Unsuitability of NOTEARS for Causal Graph Discovery
Viaarxiv icon